Trade Summary

3 days ago, Romano Kathryn, serving as Chief Accounting Officer at Krystal Biotech, Inc. (KRYS), sold 750 shares at $267.60 per share, for a total transaction value of $200,700.00. Following this transaction, Romano Kathryn now holds 22,366 shares of KRYS.

This sale represents a 3.00% decrease in Romano Kathryn's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Krystal Biotech, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.